Vfend and Movicol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vfend (voriconazole) and Movicol (polyethylene glycol 3350). Common drug interactions include granulomatous liver disease among females and hepatic failure among males.
The phase IV clinical study analyzes what interactions people have when they take Vfend and Movicol. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.
What is Vfend?
Vfend has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 12,128 Vfend users. Check the latest studies of Vfend.
What is Movicol?
Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.
52 people who take Vfend and Movicol together, and have interactions are studied.

What are the common drug interactions of Vfend and Movicol, by gender? *:
female:
- Granulomatous liver disease (a mass of inflamed granulation tissue of liver)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Cheilitis (infection of lips)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
- Facial paralysis (loss of function of face muscle)
- Febrile neutropenia (fever with reduced white blood cells)
- General physical health deterioration (weak health status)
- Hallucination (an experience involving the perception of something not present)
male:
- Hepatic failure (liver failure)
- Hepatocellular injury (liver injury)
- Hepatitis (inflammation of the liver)
- Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
- Disturbance in attention
- Septic shock (shock due to blood infection)
- Ataxia (loss of full control of bodily movements)
- Confusional state
- Diarrhoea
- Hallucination, visual (seeing things that aren't there)
What are the common drug interactions of Vfend and Movicol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Cheilitis (infection of lips)
- Photosensitivity reaction
- Skin wound
- Thermal burn (burn by heat)
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Granulomatous liver disease (a mass of inflamed granulation tissue of liver)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
60+:
- Hepatic failure (liver failure)
- Hepatocellular injury (liver injury)
- Hepatitis (inflammation of the liver)
- Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
- Disturbance in attention
- Septic shock (shock due to blood infection)
- Ataxia (loss of full control of bodily movements)
- Confusional state
- Diarrhoea
- Hallucination, visual (seeing things that aren't there)
What are the existing conditions these people have? *
- Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 27 people, 51.92%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 17 people, 32.69%
- Type 2 Diabetes: 17 people, 32.69%
- Pain: 12 people, 23.08%
- Hypokalemia (low potassium): 10 people, 19.23%
- Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 10 people, 19.23%
- Hyperkalemia (damage to or disease of the kidney): 10 people, 19.23%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 9 people, 17.31%
- Burkitt Lymphoma (cancer of the lymphatic system): 9 people, 17.31%
- Depression: 9 people, 17.31%
* Approximation only. Some reports may have incomplete information.
Do you take Vfend and Movicol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Vfend and Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vfend:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vfend and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Movicol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on voriconazole and polyethylene glycol 3350 (the active ingredients of Vfend and Movicol, respectively), and Vfend and Movicol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Artane and Navane - 2 seconds ago
- How effective is Mestinon for Myasthenia Gravis? - 3 seconds ago
- Could Norepinephrine Bitartrate cause Overdose? - 4 seconds ago
- Drug interactions of Tobramycin and Ceftazidime - 10 seconds ago
- Could Nizoral cause Drug Effect Decreased? - 11 seconds ago
- Could Oxycontin cause Metabolic Disorder? - 17 seconds ago
- Could Uloric cause Nasal Congestion? - 17 seconds ago
- Drug interactions of Omeprazole and Nexletol - 20 seconds ago
- Could Propofol cause Fainting? - 21 seconds ago
- Drug interactions of Ceftazidime and Glivec - 22 seconds ago